Tech Company M&A Transactions
BioRexis Pharmaceutical Acquisition
BioRexis Pharmaceutical was acquired by Pfizer. The transaction was announced on 2/2/2007. The acquisition price was not announced.
Transaction Overview
Company Name
Acquired By
Announced On
2/2/2007
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3400 Horizon Dr.
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Not Recorded
Overview
BioRexis Pharmaceutical Corporation uses its unique fusion technology platform to enhance the half-life, efficacy and safety of therapeutic proteins and peptides.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David King
Browse more venture capital transactions:
Prev: 2/2/2007: Brilliant Telecommunications venture capital transaction
Next: 2/2/2007: Farecast venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs